Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

Fig. 3

m6A score distribution and survival of patients in the international cohort. A m6A score distribution with patient survival status in the international cohort. The red colour indicates deceased patients while blue indicates survivors. Expression distribution of the five regulators in the international cohort, with red colour indicating higher expression and blue indicating lower expression. B Principal component analysis of high- and low-score patients based on the expression profile of five m6A regulators in the international cohort. C Kaplan-Meier curves of OS in 68 patients of the international cohort based on the m6A score. D ROC analysis of m6A score for the prediction of survival at 1, 3, and 5 years. E ROC analysis of m6A score and clinicopathological parameters for the prediction of survival at 5 years. F C-index values of m6A score and clinicopathological parameters for OS in the training cohort

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us